ABBOT STEWART,EDINGER JAMES W,FRANCKI ALEKSANDER,HARIRI ROBERT J,JANKOVIC VLADIMIR,KAPLUNOVSKY ALEKSANDR,LABAZZO KRISTEN,LAW ERIC,PADLIYA NEERAV D,PAREDES JENNIFER,WANG JIA-LUN
申请号：
SM201600377
公开号：
SMT201600377B
申请日:
2016.10.18
申请国别(地区):
SM
年份:
2017
代理人:
摘要：
The invention provides a population of placental-derived adherent cells that are CD10+, CD34-, CD105+, and CD200+ for use in a method for treatment of an individual having a disease or injury of the heart or circulatory system. Said placental-derived adherent cells may additionally be one or more of CD45-, CD90+, or OCT-4+.
